Evidence
June 15, 2020Clinical Outcomes Economic Outcomes Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar
LEARN MOREJune 15, 2020Coverage and Benefit Design Video
Source: RxInsider
LEARN MOREJune 15, 2020Clinical Outcomes Webinar / Archive
Intended Audience: Case Managers – During the CCMC New World Symposium that took place from February 28, 2019, to March 2, 2019, Nicholas B. Argento, MD, FACE, Diabetes Technology Director of Maryland Endocrine in Columbia, Maryland, presented a satellite breakfast symposium on continuous glucose monitoring (CGM) that was sponsored by Dexcom.
LEARN MORE
Leading CGM Innovation with Dexcom G6® – The Only Fully Interoperable, Zero Fingerstick CGM System – A Science & Innovation Theater held in conjunction with the Academy of Managed Care Pharmacy’s Annual Meeting 2019
June 15, 2020CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar
Description: Dexcom G6® is the first CGM to receive the integrated CGM classification by the FDA. Dexcom G6® is approved for use as a standalone CGM and for integration with bluetooth connected insulin pens and automated insulin delivery systems. This presentation will highlight Dexcom’s technology, connected ecosystem, Google/Verily partnership, and future developments including EHR integration, population-level insights, and decision support algorithms.
December 21, 2019CGM Technology and Digital Health CGM Best Practices / Interview
Expert: Thomas Danne, MD, Professor of Pediatrics at Children’s Hospital Auf der Bult
Summary: In this 3-part video interview Professor Danne discussion the opportunities and challenges presented by glycemic control, time in range and reduction in diabetes-related complications, virtual care and the future of CGM.
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Source: AMCP Science and Innovation Theater Webinar
LEARN MOREJune 15, 2020Coverage and Benefit Design Video
Source: RxInsider
LEARN MOREJune 15, 2020Clinical Outcomes Webinar / Archive
Intended Audience: Case Managers – During the CCMC New World Symposium that took place from February 28, 2019, to March 2, 2019, Nicholas B. Argento, MD, FACE, Diabetes Technology Director of Maryland Endocrine in Columbia, Maryland, presented a satellite breakfast symposium on continuous glucose monitoring (CGM) that was sponsored by Dexcom.
LEARN MORELeading CGM Innovation with Dexcom G6® – The Only Fully Interoperable, Zero Fingerstick CGM System – A Science & Innovation Theater held in conjunction with the Academy of Managed Care Pharmacy’s Annual Meeting 2019
June 15, 2020CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar
Description: Dexcom G6® is the first CGM to receive the integrated CGM classification by the FDA. Dexcom G6® is approved for use as a standalone CGM and for integration with bluetooth connected insulin pens and automated insulin delivery systems. This presentation will highlight Dexcom’s technology, connected ecosystem, Google/Verily partnership, and future developments including EHR integration, population-level insights, and decision support algorithms.
December 21, 2019CGM Technology and Digital Health CGM Best Practices / Interview
Expert: Thomas Danne, MD, Professor of Pediatrics at Children’s Hospital Auf der Bult
Summary: In this 3-part video interview Professor Danne discussion the opportunities and challenges presented by glycemic control, time in range and reduction in diabetes-related complications, virtual care and the future of CGM.
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Source: RxInsider
LEARN MOREJune 15, 2020Clinical Outcomes Webinar / Archive
Intended Audience: Case Managers – During the CCMC New World Symposium that took place from February 28, 2019, to March 2, 2019, Nicholas B. Argento, MD, FACE, Diabetes Technology Director of Maryland Endocrine in Columbia, Maryland, presented a satellite breakfast symposium on continuous glucose monitoring (CGM) that was sponsored by Dexcom.
LEARN MORELeading CGM Innovation with Dexcom G6® – The Only Fully Interoperable, Zero Fingerstick CGM System – A Science & Innovation Theater held in conjunction with the Academy of Managed Care Pharmacy’s Annual Meeting 2019
June 15, 2020CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar
Description: Dexcom G6® is the first CGM to receive the integrated CGM classification by the FDA. Dexcom G6® is approved for use as a standalone CGM and for integration with bluetooth connected insulin pens and automated insulin delivery systems. This presentation will highlight Dexcom’s technology, connected ecosystem, Google/Verily partnership, and future developments including EHR integration, population-level insights, and decision support algorithms.
December 21, 2019CGM Technology and Digital Health CGM Best Practices / Interview
Expert: Thomas Danne, MD, Professor of Pediatrics at Children’s Hospital Auf der Bult
Summary: In this 3-part video interview Professor Danne discussion the opportunities and challenges presented by glycemic control, time in range and reduction in diabetes-related complications, virtual care and the future of CGM.
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Intended Audience: Case Managers – During the CCMC New World Symposium that took place from February 28, 2019, to March 2, 2019, Nicholas B. Argento, MD, FACE, Diabetes Technology Director of Maryland Endocrine in Columbia, Maryland, presented a satellite breakfast symposium on continuous glucose monitoring (CGM) that was sponsored by Dexcom.
LEARN MORELeading CGM Innovation with Dexcom G6® – The Only Fully Interoperable, Zero Fingerstick CGM System – A Science & Innovation Theater held in conjunction with the Academy of Managed Care Pharmacy’s Annual Meeting 2019
June 15, 2020CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar
Description: Dexcom G6® is the first CGM to receive the integrated CGM classification by the FDA. Dexcom G6® is approved for use as a standalone CGM and for integration with bluetooth connected insulin pens and automated insulin delivery systems. This presentation will highlight Dexcom’s technology, connected ecosystem, Google/Verily partnership, and future developments including EHR integration, population-level insights, and decision support algorithms.
December 21, 2019CGM Technology and Digital Health CGM Best Practices / Interview
Expert: Thomas Danne, MD, Professor of Pediatrics at Children’s Hospital Auf der Bult
Summary: In this 3-part video interview Professor Danne discussion the opportunities and challenges presented by glycemic control, time in range and reduction in diabetes-related complications, virtual care and the future of CGM.
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Leading CGM Innovation with Dexcom G6® – The Only Fully Interoperable, Zero Fingerstick CGM System – A Science & Innovation Theater held in conjunction with the Academy of Managed Care Pharmacy’s Annual Meeting 2019
Source: AMCP Science and Innovation Theater Webinar
Description: Dexcom G6® is the first CGM to receive the integrated CGM classification by the FDA. Dexcom G6® is approved for use as a standalone CGM and for integration with bluetooth connected insulin pens and automated insulin delivery systems. This presentation will highlight Dexcom’s technology, connected ecosystem, Google/Verily partnership, and future developments including EHR integration, population-level insights, and decision support algorithms.
December 21, 2019CGM Technology and Digital Health CGM Best Practices / Interview
Expert: Thomas Danne, MD, Professor of Pediatrics at Children’s Hospital Auf der Bult
Summary: In this 3-part video interview Professor Danne discussion the opportunities and challenges presented by glycemic control, time in range and reduction in diabetes-related complications, virtual care and the future of CGM.
Expert: Thomas Danne, MD, Professor of Pediatrics at Children’s Hospital Auf der Bult
Summary: In this 3-part video interview Professor Danne discussion the opportunities and challenges presented by glycemic control, time in range and reduction in diabetes-related complications, virtual care and the future of CGM.
